Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Jun 4;17:E41. doi: 10.5888/pcd17.190374

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Preventing Chronic Disease is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.

PMC Copyright notice

Graphic shows the process used to engage pharmacists in the National Diabetes Prevention Program with 4 boxes at top and lists underneath each box. Three boxes represent the 3 phases in the process. Specific activities for each phase are listed and ultimately lead to the fourth box, titled desired outcomes. Each phase is shown to have been influenced by continuous stakeholder engagement. The first box is phase 1, exploring the pharmacy ecosystem and stakeholder engagement from January 2016 to April 2017. Phase 1 activities included interviewing key informants, analyzing the pharmacy landscape and ecosystem, and establishing an internal advisory committee of pharmacists and CDC staff. These actions led to identification of a pharmacy stakeholder group that shared insights on how to engage the pharmacy sector with the National Diabetes Prevention Program. The next box is phase 2 when, from April 2017 through May 2018, gathering feedback and developing the Pharmacy Action Guide was the only activity. Phase 3 focuses on promoting and evaluating efforts from May 2018 to the present. Activities in phase 3 included holding a pharmacy stakeholder meeting on how to promote the Pharmacy Action Guide and engage pharmacists, developing promotional resources, disseminating the Pharmacy Action Guide and promotional materials, and evaluating and measuring results. The desired outcomes of these activities are for pharmacists to read the Pharmacy Action Guide, recognize its significance and the role they can play in type 2 diabetes prevention, and to implement tier 1, 2, and/or 3 activities in their pharmacies. As a result, pharmacy patients will become more aware of prediabetes, their personal risk for type 2 diabetes, and the National Diabetes Prevention Program lifestyle change program. The last listed outcome of these efforts is an increase in the number of patients with prediabetes who enroll in and complete the National Diabetes Prevention Program lifestyle change program. The words Continuous Stakeholder Engagement and Feedback are centered at the bottom. — Model for pharmacist engagement in the National Diabetes Prevention Program.